FrancophonIA/ELRC3.0 huggingface dataset:
English: EU/1/12/780/001 10 x 1 film-coated tablets EU/1/12/780/002 14 x 1 film-coated tablets EU/1/12/780/003 28 x 1 film-coated tablets EU/1/12/780/004 30 x 1 film-coated tablets EU/1/12/780/005 56 x 1 film-coated tablets EU/1/12/780/006 60 x 1 film-coated tablets EU/1/12/780/007 84 x 1 film-coated tablets EU/1/12/780/008 90 x 1 film-coated tablets EU/1/12/780/009 98 x 1 film-coated tablets EU/1/12/780/010 100 x 1 film-coated tablets EU/1/12/780/011 120 x 1 film-coated tablets
Croatian: EU/1/12/780/001 10 x 1 filmom obložena tableta EU/1/12/780/002 14 x 1 filmom obložena tableta EU/1/12/780/003 28 x 1 filmom obložena tableta EU/1/12/780/004 30 x 1 filmom obložena tableta EU/1/12/780/005 56 x 1 filmom obložena tableta EU/1/12/780/006 60 x 1 filmom obložena tableta EU/1/12/780/007 84 x 1 filmom obložena tableta EU/1/12/780/008 90 x 1 filmom obložena tableta EU/1/12/780/009 98 x 1 filmom obložena tableta EU/1/12/780/010 100 x 1 filmom obložena tableta EU/1/12/780/011 120 x 1 filmom obložena tableta
English: EU/1/12/780/015 10 x 1 film-coated tablets EU/1/12/780/016 14 x 1 film-coated tablets EU/1/12/780/017 28 x 1 film-coated tablets EU/1/12/780/018 30 x 1 film-coated tablets EU/1/12/780/019 56 x 1 film-coated tablets EU/1/12/780/020 60 x 1 film-coated tablets EU/1/12/780/021 84 x 1 film-coated tablets EU/1/12/780/022 90 x 1 film-coated tablets EU/1/12/780/023 98 x 1 film-coated tablets EU/1/12/780/024 100 x 1 film-coated tablets EU/1/12/780/025 120 x 1 film-coated tablets
Croatian: EU/1/12/780/015 10 x 1 filmom obložena tableta EU/1/12/780/016 14 x 1 filmom obložena tableta EU/1/12/780/017 28 x 1 filmom obložena tableta EU/1/12/780/018 30 x 1 filmom obložena tableta EU/1/12/780/019 56 x 1 filmom obložena tableta EU/1/12/780/020 60 x 1 filmom obložena tableta EU/1/12/780/021 84 x 1 filmom obložena tableta EU/1/12/780/022 90 x 1 filmom obložena tableta EU/1/12/780/023 98 x 1 filmom obložena tableta EU/1/12/780/024 100 x 1 filmom obložena tableta EU/1/12/780/025 120 x 1 filmom obložena tableta
English: Jentadueto 2.5 mg/850 mg film-coated tablets EU/1/12/780/001 (10 x 1 film-coated tablets) EU/1/12/780/002 (14 x 1 film-coated tablets) EU/1/12/780/003 (28 x 1 film-coated tablets) EU/1/12/780/004 (30 x 1 film-coated tablets) EU/1/12/780/005 (56 x 1 film-coated tablets) EU/1/12/780/006 (60 x 1 film-coated tablets) EU/1/12/780/007 (84 x 1 film-coated tablets) EU/1/12/780/008 (90 x 1 film-coated tablets) EU/1/12/780/009 (98 x 1 film-coated tablets) EU/1/12/780/010 (100 x 1 film-coated tablets) EU/1/12/780/011 (120 x 1 film-coated tablets) EU/1/12/780/012 (14 film-coated tablets, bottle) EU/1/12/780/013 (60 film-coated tablets, bottle) EU/1/12/780/014 (180 film-coated tablets, bottle) EU/1/12/780/029 (120 (2 x 60 x 1) film-coated tablets) EU/1/12/780/030 (180 (2 x 90 x 1) film-coated tablets) EU/1/12/780/031 (200 (2 x 100 x 1) film-coated tablets)
Croatian: Jentadueto 2,5 mg/850 mg filmom obložene tablete EU/1/12/780/001 (10 x 1 filmom obložena tableta) EU/1/12/780/002 (14 x 1 filmom obložena tableta) EU/1/12/780/003 (28 x 1 filmom obložena tableta) EU/1/12/780/004 (30 x 1 filmom obložena tableta) EU/1/12/780/005 (56 x 1 filmom obložena tableta) EU/1/12/780/006 (60 x 1 filmom obložena tableta) EU/1/12/780/007 (84 x 1 filmom obložena tableta) EU/1/12/780/008 (90 x 1 filmom obložena tableta) EU/1/12/780/009 (98 x 1 filmom obložena tableta) EU/1/12/780/010 (100 x 1 filmom obložena tableta) EU/1/12/780/011 (120 x 1 filmom obložena tableta) EU/1/12/780/012 (14 filmom obloženih tableta, boca) EU/1/12/780/013 (60 filmom obloženih tableta, boca) EU/1/12/780/014 (180 filmom obloženih tableta, boca) EU/1/12/780/029 (120 (2 x 60 x 1) filmom obloženih tableta) EU/1/12/780/030 (180 (2 x 90 x 1) filmom obloženih tableta) EU/1/12/780/031 (200 (2 x 100 x 1) filmom obloženih tableta)
English: - if you drink alcohol to excess, either every day or only from time to time (see section 'Jentadueto with alcohol').
Croatian: To može dovesti do nedostatne opskrbe tkiva kisikom i izložiti Vas riziku od laktacidoze (vidjeti dio „Upozorenja i mjere opreza“); - ako imate probleme s jetrom; - ako konzumirate alkohol, bilo svakodnevno ili tek povremeno (vidjeti dio „Jentadueto i alkohol“).
English: Difference from placebo (adjusted mean) (95% CI) Patients (n, %) achieving HbA1c
Croatian: Bolesnici (n, %) s postignutim HbA1c <7%
English: Propylene glycol
Croatian: Bulozni pemfigoid
English: The prospective randomised (UKPDS) study has established the long-term benefit of intensive blood glucose control in type 2 diabetes.
Croatian: Prospektivno randomizirano (UKPDS) ispitivanje je utvrdilo dugotrajne pozitivne učinke intenzivne kontrole glukoze u krvi u bolesnika s dijabetesom tipa 2. Analiza rezultata u bolesnika s prekomjernom tjelesnom težinom liječenih metforminom nakon neuspjeha samo dijete, pokazala je:
English: - If you get any side effects, talk to your doctor, pharmacist or nurse.
Croatian: - Ako primjetite bilo koju nuspojavu, potrebno je obavijestiti liječnika, ljekarnika ili medicinsku sestru.
English: Jentadueto 2.5 mg/850 mg film-coated tablets
Croatian: Jentadueto 2,5 mg/850 mg filmom obložene tablete linagliptin/metforminklorid
English: Renal function
Croatian: Funkcija bubrega
English: Jentadueto 2.5 mg/1,000 mg film-coated tablets
Croatian: Jentadueto 2,5 mg/1000 mg filmom obložene tablete linagliptin/metforminklorid
English: Co-administration of metformin with
Croatian: Istodobna primjena metformina s
English: 500 mg Twice Daily
Croatian: Linagliptin 2,5 mg dvaput dnevno metforminklorid 500 mg dvaput dnevno
English: - alcohol-containing medicines.
Croatian: OZNAČIVANJE I UPUTA O LIJEKU
English: Constipation uncommon
Croatian: Konstipacija manje često
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription.
Croatian: PRILOG II. A. PROIZVOĐAČ(I) ODGOVORAN(NI) ZA PUŠTANJE SERIJE LIJEKA U PROMET B. UVJETI ILI OGRANIČENJA VEZANI UZ OPSKRBU I PRIMJENU C. OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET D. UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU LIJEKA
English: 14 October 2016 EMA/610687/2016 EMEA/H/C/004080
Croatian: EMA/610687/2016 EMEA/H/C/004080
English: • gynaecological infections;
Croatian: • ginekološke upale;
English: • community-acquired pneumonia (infection of the lungs caught away from hospital);
Croatian: • izvanbolničke upale pluća (upale pluća dobivene izvan bolnice);
English: In its letter notifying the Agency of the withdrawal of the application, the company stated that the withdrawal of the application is based on commercial reasons following an evaluation of the current market situation.
Croatian: U pismu u kojem obavještava Agenciju o povlačenju primjene, tvrtka je navela da je do povlačenja primjene došlo zbog komercijalnih razloga nakon procjene trenutačnog stanja na tržištu.
English: This upsets the essential functions that keep the cells alive, and kills the bacteria.
Croatian: To ometa glavne funkcije živih bakterija i ubija bakterije.
English: The application was withdrawn after the CHMP had evaluated the initial documentation provided by the company and formulated a list of questions.
Croatian: Zahtjev je povučen nakon što je CHMP ocijenio inicijalnu dokumentaciju koju je tvrtka dostavila i sastavio popis pitanja.
English: Ertapenem attaches to certain proteins on the surface of the bacteria cells.
Croatian: Ertapenem se veže za određene proteine na površini bakterijskih stanica.
English: Ertapenem Hospira was expected to be used in adults and children aged over 3 months to treat the following infections, if caused by bacteria likely to be killed by ertapenem:
Croatian: Hospira trebao se koristiti kod odraslih i djece starije od 3 mjeseca za liječenje sljedećih upala, ako ih uzrokuje bakterija koju će ertapenem vjerojatno uništiti:
English: Because Ertapenem Hospira was developed as a generic medicine, the company presented the results of studies to show the quality of the medicine.
Croatian: Budući da je lijek Ertapenem Hospira razvijen kao generički lijek, tvrtka je predstavila rezultate ispitivanja kojima se dokazuje kvaliteta lijeka.
English: The company had not yet responded to the questions at the time of the withdrawal.
Croatian: U trenutku povlačenja tvrtka još nije bila dostavila svoje odgovore.
English: The CHMP had concerns about the choice of the starting materials for making the active substance, the process used to manufacture the medicine, the method for testing the purity of the medicine and the medicine's shelf life.
Croatian: CHMP bio je zabrinut u pogledu izbora početnih materijala za stvaranje djelatne tvari, postupka koji se koristi za proizvodnju lijeka, metode za ispitivanje čistoće lijeka i vijeka trajanja lijeka.
English: Ertapenem Hospira was also expected to be used to prevent infection at the site of colorectal surgery (surgery in the lower part of the bowel, including the rectum and anus).
Croatian: Hospira trebao se koristiti i za prevenciju upale na mjestu kolorekltalne operacije (kirurška operacija na donjem dijelu crijeva, uključujući rektum i anus).
English: Ertapenem can work on a range of different bacteria.
Croatian: Ertapenem djeluje na nizu različitih bakterija.
English: It was to be available as a vial containing a powder which is dissolved before use to make up a solution for infusion (drip) into a vein.
Croatian: Dostupan je u bočici koja sadrži prah koji se otapanjem prije upotrebe pretvara u otopinu za ubrizgavanje (drip) u venu.
English: At the time of the withdrawal, the CHMP was of the opinion that the company had not addressed its concerns and the quality of Ertapenem Hospira had not been demonstrated.
Croatian: U vrijeme povlačenja CHMP je smatrao da tvrtka nije riješila te probleme te da kvaliteta lijeka Ertapenem Hospira nije pokazana.
English: The active substance in Ertapenem Hospira and Invanz, ertapenem, belongs to a group of antibiotics known as ‘carbapenems'.
Croatian: Djelatna tvar u lijeku Ertapenem Hospira i Invanz, ertapenem, ubraja se u skupinu antibiotika poznatih pod nazivom „karbapenemi”.
English: This means that Ertapenem Hospira was intended to be similar to a ‘reference medicine' already authorised in the European Union called Invanz.
Croatian: To znači da je Ertapenem Hospira sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Invanz.
English: On 13 September 2016, Hospira UK Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Ertapenem Hospira, for the treatment of certain infections and for the prevention of infection in colorectal surgery.
Croatian: Dana 13. rujna 2016. tvrtka Hospira UK Limited službeno je obavijestila Odbor za lijekove za humanu uporabu (CHMP) kako želi povući svoj zahtjev za odobrenje za stavljanje u promet lijeka Ertapenem
English: Based on the review of the data, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Ertapenem Hospira could not have been approved for the treatment of infections and for the prevention of infection in colorectal surgery.
Croatian: Na temelju pregleda podataka u vrijeme povlačenja, CHMP je smatrao da postoje problemi te je njegovo privremeno mišljenje bilo da nije moguće dati odobrenje za lijek Ertapenem Hospira za liječenje upala i prevenciju kolorektalne kirurške operacije.
English: What is Ertapenem Hospira?
Croatian: Što je Ertapenem Hospira?
English: Ertapenem Hospira was developed as a ‘generic medicine'.
Croatian: Ertapenem Hospira razvijen je kao „generički lijek”.
English: How does Ertapenem Hospira work?
Croatian: Kako djeluje Ertapenem Hospira?
English: • foot infections in diabetes patients.
Croatian: • upale stopala kod dijabetičara.
English: Ertapenem Hospira is an antibiotic medicine that contains the active substance ertapenem.
Croatian: Hospira antibiotički je lijek koji sadrži djelatnu tvar ertapenem.
English: Ertapenem Hospira is expected to work in the same way as the reference medicine, Invanz.
Croatian: Hospira trebao je djelovati na isti način kao i referentni lijek, Invanz.
English: • infections in the abdomen;
Croatian: • upale abdomena;
English: No further studies were carried out because Ertapenem Hospira is a generic medicine that is given by infusion and contains the same active substance as the reference medicine, Invanz.
Croatian: Hospira generički lijek koji se daje infuzijom i koji sadrži istu djelatnu tvar kao i referentni lijek Invanz.
English: What was Ertapenem Hospira expected to be used for?
Croatian: Hospira trebao koristiti?
English: EMA/610687/2016
Croatian: 14. listopada 2016.
English: You can take them with meals or between meals.
Croatian: Možete ih uzeti uz obrok ili između obroka.
English: Frequency not known (cannot be estimated from the available data)
Croatian: Učestalost nepoznata (ne može se procijeniti iz dostupnih podataka)
English: (1) Open the flap on the left end.
Croatian: (1) Otvorite preklopac na lijevom kraju.
English: The safety database from these studies comprises 923 patients.
Croatian: Baza sigurnosnih podataka iz ovih ispitivanja uključuje 923 bolesnika.
English: Avoid touching your nose, eyes, and other parts of the body.
Croatian: Izbjegavajte dodirivati nos, oči i druge dijelove tijela.
English: If this is not the case, your treatment will be delayed.
Croatian: Ako to nije slučaj, Vaše će liječenje biti odgođeno.
English: Rash, alopecia.
Croatian: osip, alopecija.
English: Your weight
Croatian: Vaša težina
English: - if you have active cancer.
Croatian: ako imate aktivni rak.
English: Your doctor may need to supervise you more closely.
Croatian: Liječnik će Vas možda trebati pažljivije pratiti.
English: • Information on pregnancy prevention.
Croatian: • Informacije o sprječavanju trudnoće.
English: Viale Pasteur, 10 20014 Nerviano (MI) Italy
Croatian: Viale Pasteur, 10 20014 Nerviano (MI) Italija
English: Criteria for initiating and continuing therapy
Croatian: Kriteriji za započinjanje i nastavak terapije
English: Your doctor will tell you what to do if you have to take these medicines.
Croatian: Liječnik će Vas obavijestiti što da činite ako morate uzimati ove lijekove.
English: For details, see Tables 1 and 2 below.
Croatian: Za detaljnije informacije, vidjeti tablice 1 i 2 niže.
English: Re-initiation of therapy after year 4 has not been studied.
Croatian: Ponovno uvođenje terapije nakon 4. godine nije ispitano.
English: You will need one or more packs to provide the correct number of tablets.
Croatian: Bit će Vam potrebno jedno ili više pakiranja da biste imali točan broj tableta.
English: PML is a serious condition that may lead to severe disability or death.
Croatian: PML je ozbiljno stanje koje može dovesti do teške onesposobljenosti ili smrti.
English: Example: if you start your treatment mid April, you take your tablets as shown.
Croatian: Primjer: ako započnete liječenje sredinom travnja, uzimate tablete kako je prikazano.
English: Treatment consists of careful observation and initiation of appropriate supportive measures.
Croatian: Liječenje se sastoji od pažljivog promatranja i uvođenja odgovarajućih potpornih mjera.
English: R-Pharm Germany GmbH Heinrich-Mack-Strasse 35 89257 Illertissen Germany
Croatian: R-Pharm Germany GmbH Heinrich-Mack-Strasse 35 89257 Illertissen Njemačka
English: - if you are pregnant or breast-feeding (see also 'Pregnancy and breast-feeding').
Croatian: - ako ste trudni ili dojite (pogledajte također „Trudnoća i dojenje”).
English: Your doctor will give you guidance on appropriate methods of contraception.
Croatian: Liječnik će Vas uputiti na prikladne metode kontracepcije.
English: When you receive your supply of medicine, check that you have the correct number of tablets.
Croatian: Kad dobijete zalihu lijeka, provjerite imate li točan broj tableta.
English: Your doctor will decide if you need to stop treatment or not.
Croatian: Liječnik će odlučiti trebate li prekinuti liječenje ili ne.
English: 40 to less than 50 kg 50 to less than 60 kg 60 to less than 70 kg 70 to less than 80 kg 80 to less than 90 kg 90 to less than 100 kg 100 to less than 110 kg
Croatian: 40 do manje od 50 kg 50 do manje od 60 kg 60 do manje od 70 kg 70 do manje od 80 kg 80 do manje od 90 kg 90 do manje od 100 kg 100 do manje od 110 kg
English: The primary objective of this study was safety, while efficacy endpoints were exploratory.
Croatian: Primarni cilj ovog ispitivanja bio je ispitati sigurnost, dok su mjere ishoda djelotvornosti bile eksplorativne.
English: The tablets can be taken independent of food intake.
Croatian: Tablete se mogu uzimati neovisno o uzimanju hrane.
English: An effect on disability progression could not be shown in either subgroup.
Croatian: Učinak na napredovanje onesposobljenosti nije se moglo pokazati ni u jednoj podskupini.
English: Wash your hands thoroughly with soap and water.
Croatian: Temeljito operite ruke vodom i sapunom.
English: - if you are HIV positive, meaning you are infected with the human immunodeficiency virus (HIV).
Croatian: - ako ste HIV-pozitivni, što znači da ste zaraženi virusom humane imunodeficijencije (HIV).
English: Gustav Mahlerplein 102 1082 MA Amsterdam The Netherlands
Croatian: Gustav Mahlerplein 102 1082 MA Amsterdam Nizozemska
English: Grade 4 lymphopenia was seen in less than 1% of the patients.
Croatian: Limfopenija 4. stupnja bila je opažena u manje od 1 % bolesnika.
English: Table 3 Clinical outcomes in the CLARITY study (96 weeks)
Croatian: Tablica 3 Klinički ishodi u ispitivanju CLARITY (96 tjedana)
English: Your doctor will tell you the number of tablets to take
Croatian: Liječnik će Vam reći koliki broj tableta da uzmete
English: Infection with human immunodeficiency virus (HIV).
Croatian: Infekcija virusom humane imunodeficijencije (HIV).
English: 1 tablet 4 tablets 5 tablets 6 tablets 7 tablets 8 tablets
Croatian: 1 tableta 4 tablete 5 tableta 6 tableta 7 tableta 8 tableta
English: It is important to talk to your doctor if you think you have an infection.
Croatian: Morate se obratiti liječniku ako mislite da imate neku infekciju.
English: How to take your medicine
Croatian: Kako uzimati lijek
English: Patients were required to have at least 1 relapse in the previous 12 months.
Croatian: Bolesnici su trebali imati najmanje 1 relaps u prethodnih 12 mjeseci.
English: The prescriber / patient guide should include information about the following safety concerns:
Croatian: Vodič za propisivače/bolesnike treba uključivati informacije o sljedećim sigurnosnim pitanjima:
English: Concomitant treatment is not recommended.
Croatian: Ne preporučuje se istodobna primjena.
English: You will need to wait between 4 and 6 weeks for the vaccination to take effect.
Croatian: Morat ćete pričekati između 4 i 6 tjedana kako bi cjepivo počelo djelovati.
English: 110 kg and above
Croatian: 110 kg i više
English: Dose and time dependence
Croatian: Doza i ovisnost o vremenu
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 22 August 2017
Croatian: Datum prvog odobrenja: 22. kolovoza 2017.
English: Once you have completed the 2 treatment courses over 2 years, your doctor will continue to monitor your health for another 2 years, in which you do not need to take the medicine.
Croatian: Nakon što završite 2 ciklusa liječenja u 2 godine, liječnik će nastaviti pratiti Vaše zdravstveno stanje još 2 godine, tijekom kojih ne trebate uzimati ovaj lijek.
English: Do not take MAVENCLAD if you are pregnant or trying to become pregnant.
Croatian: Nemojte uzeti MAVENCLAD ako ste trudni ili pokušavate zatrudnjeti.
English: Efficacy in patients with high disease activity
Croatian: Djelotvornost u bolesnika s visoko aktivnom bolešću
English: Example: if you weigh 85 kg and are about to start treatment week 1, you will be given 8 tablets.
Croatian: Primjer: ako imate 85 kg i upravo ćete početi s 1. tjednom liječenja, dobit ćete 8 tableta.
English: If your daily dose is 2 tablets, take them at the same time.
Croatian: Ako Vam je dnevna doza 2 tablete, uzmite ih u isto vrijeme.
English: You may have to have the blood irradiated to prevent complications.
Croatian: Možda će se krv morati ozračiti kako bi se spriječile komplikacije.
English: This however does not result in any drug accumulation after once daily dosing as this half-life only accounts for a small portion of the AUC.
Croatian: To, međutim, ne dovodi do nakupljanja lijeka nakon doziranja jedanput dnevno jer je ovaj poluvijek zaslužan samo za mali udio AUC-a.
English: If you have taken more tablets than you should, contact your doctor immediately.
Croatian: Ako ste uzeli više tableta nego što ste trebali, odmah se obratite liječniku.
English: Push the tray back into the carton.
Croatian: Gurnite pliticu natrag u kutiju.
English: Parameter
Croatian: Parametar
English: • patients with 1 relapse in the previous year and at least 1 T1 Gd+ lesion or 9 or more T2 lesions,
Croatian: • bolesnike s 1 relapsom u prethodnoj godini i najmanje 1 T1 Gd+ lezijom ili 9 ili više T2 lezija,
English: OTHER SPECIAL WARNING, IF NECESSARY Cytotoxic: Handle with caution.
Croatian: DRUGO POSEBNO UPOZORENJE, AKO JE POTREBNO Citotoksično: rukovati s oprezom.
English: Your doctor will decide the best treatment options for you.
Croatian: Liječnik će odlučiti koji je najbolji izbor liječenja za Vas.
English: If such signs and symptoms occur, antiinfective treatment should be initiated as clinically indicated.
Croatian: Ako se pojave takvi znakovi i simptomi, potrebno je započeti antiinfektivno liječenje prema kliničkim indikacijama.
English: Very rare side effect - may affect up to 1 in 10,000 people - tuberculosis
Croatian: Vrlo rijetke nuspojave - mogu se javiti u do 1 na 10 000 osoba - tuberkuloza.
English: Place your hand under the blister pack and push 1 or 2 tablet(s) into your hand, according to your prescribed dose.
Croatian: Postavite ruku ispod blister pakiranja i potisnite 1 ili 2 tablete u ruku, sukladno dozi koja Vam je propisana.
English: Progressive multifocal leukoencephalopathy (PML) If you believe your MS is getting worse or if you notice any new symptoms, for example changes in mood or behaviour, memory lapses, speech and communication difficulties, talk to your doctor as soon as possible.
Croatian: Progresivna multifokalna leukoencefalopatija (PML) Ako ste uvjereni da Vam se MS pogoršava ili ako opazite neke nove simptome, na primjer promjene raspoloženja ili ponašanja, tegobe s pamćenjem, poteškoće u govoru i komunikaciji, što prije se obratite svom liječniku.
English: As a precautionary measure, you should follow standard cancer screening recommendations, as advised by your doctor.
Croatian: Kao mjera opreza, trebate se pridržavati standardnih preporuka za probir na rak, kako Vam je savjetovao liječnik.
English: Pack sizes of 1, 4, 5, 6, 7 or 8 tablets.
Croatian: Veličine pakiranja od 1, 4, 5, 6, 7 ili 8 tableta.
English: In mice, there were no effects on fertility or the reproductive function of offspring.
Croatian: U miševa nije bilo učinaka na plodnost ili reproduktivnu funkciju potomstva.
English: Depending on the total number of tablets you have been prescribed, you have to take them over 4 or 5 days, in each treatment week.
Croatian: Ovisno o ukupnom broju tableta koji Vam je propisan, morate ih uzeti tijekom 4 ili 5 dana u svakom tjednu liječenja.
English: Pharmacotherapeutic group: Selective Immunosuppressants, ATC code: L04AA40
Croatian: Farmakoterapijska skupina: selektivni imunosupresivi, ATK oznaka: L04AA40
English: Harderian gland tumours are not considered to be of clinical relevance, as humans do not have comparable anatomical structures.
Croatian: Tumori Harderove žlijezde ne smatraju se klinički važnima, jer ljudi nemaju usporedivu anatomsku strukturu.
English: Table 3 shows how many tablets (1 or 2 tablets) you have to take on each day.
Croatian: Tablica 3 prikazuje koliko tableta (1 ili 2 tablete) morate uzeti svakog dana.
English: Talk to your doctor if you have previously had cancer.
Croatian: Obratite se liječniku ako ste imali rak.
English: If you miss a dose and do not remember it until the following day
Croatian: Ako propustite dozu i sjetite se tek sljedećeg dana